The Study of Molecular Risk Panels (70-gene Assay) in Chinese Breast Cancer Patients

Completed

Conditions studied: Chinese

In brief

This study is experimental and will prospectively assess the proportion of patients in the two (2) MammaPrint Risk categories in patients of Chinese descent.

Key facts

Study ID

NCT02669745

Run by

Agendia

People needed

64

Starts

2012-01-01

Expected to finish

2019-05-01

Last updated by the study team

2019-07-02

Who can join

Age: 18 and older, up to 70. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Females aged 18 year to 70 year,
• diagnosis of Stage I or Stage II (excluding those involving more than 3 lymph nodes) Breast Cancer
• Chinese descent

You may not qualify if…

• Stage II Breast Cancer with more than 3 positive lymph nodes

Where it is running

• Columbia University Medical Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.